Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/1918e4cd-5d17-42c0-a068-f48122b68052/

CRL

Charles River Laboratories
Chart
$181.34
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.25
OS Score
24.0%
Value
27.0%
Quality
73.0%
Momentum
5/9
F-Score
0.255
QV
Strategy Eligibility
0 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
24.0%ile
P/S
2.2×
P/B
3.0×
FCF Yield
0.073
EBITDA/EV
0.071
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
75.00000000
/100 — 1=cheapest
VC2 (Trending Value)
80.00000000
/100
VC3 (Buyback)
80.00000000
/100
FCF yield of 7.3% is strong — the business generates significant free cash relative to price. VC2 score of 80.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
27.0%ile
ROE
-0.063
ROA
-0.024
Net Margin
-0.046
Op Margin
0.113
GPA
0.166
D/E
1.61
Current
1.36
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.001
Stability
5.168
lower=better
Accruals
-0.102
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
73.0%ile
6M Return
-1.6%
12M Return
25.3%
12-1 Mom
22.8%
Risk-Adj
0.44
Vol 252d
51.3%
Vol 60d
117.8%
↑ Expanding
Max DD 12M
-31.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 23% is very strong — a clear uptrend. Near-term vol (118%) is expanding vs long-term (51%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.25
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
7.2%
Sector Quality %ile
9.8%
P/B z-score
-0.17
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Volatility Expanding
60-day vol (118%) significantly exceeds 252-day (51%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
53.2% avg (5 factors)
Quality
D
34.4% avg (8 factors)
Momentum
C
49.2% avg (4 factors)
Risk
D
31.2% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.250—1
Value %ile0.240—1
Quality %ile0.270—1
Momentum %ile0.730—1
F-Score5.000—0
Confidence0.879—1
Volatility0.513—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
2.20
Price / Book
3.02
Price / Cash Flow
14.62
FCF Yield
7.3%
EBITDA / EV
7.1%
Sales Yield (1/P·S)
0.3549
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-6.3%
Return on Assets
-2.4%
Net Margin
-4.6%
Operating Margin
11.3%
Gross Profit / Assets
Novy-Marx GPA
16.6%
Debt / Equity
1.61
Current Ratio
1.36
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.102
MomentumPrice trend strength over different horizons
6M Return
-1.6%
12M Return
25.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
22.8%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.44
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
0.1%
Earnings Stability (CV)
Lower = more stable
5.168
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
75
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
80
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
80
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity